IRIS UniCatt

Tolusso, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.647
NA - Nord America 3.612
AS - Asia 1.558
SA - Sud America 327
AF - Africa 45
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 6
Totale 9.205
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.567
DE - Germania 814
IT - Italia 619
CN - Cina 603
SE - Svezia 575
SG - Singapore 553
PL - Polonia 494
FR - Francia 339
BR - Brasile 299
IE - Irlanda 177
UA - Ucraina 162
GB - Regno Unito 124
ID - Indonesia 110
FI - Finlandia 101
IN - India 98
RU - Federazione Russa 51
BE - Belgio 48
TR - Turchia 38
NL - Olanda 31
CA - Canada 28
HK - Hong Kong 28
KR - Corea 27
AT - Austria 24
CI - Costa d'Avorio 24
JP - Giappone 21
CZ - Repubblica Ceca 14
VN - Vietnam 13
CH - Svizzera 12
AR - Argentina 11
IR - Iran 11
MX - Messico 11
BD - Bangladesh 10
LT - Lituania 9
MA - Marocco 8
RO - Romania 7
ES - Italia 6
EU - Europa 6
GR - Grecia 6
IL - Israele 6
AU - Australia 5
EE - Estonia 5
LA - Repubblica Popolare Democratica del Laos 5
LV - Lettonia 5
ZA - Sudafrica 5
CO - Colombia 4
HU - Ungheria 4
IQ - Iraq 4
PK - Pakistan 4
UZ - Uzbekistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BG - Bulgaria 3
CL - Cile 3
DK - Danimarca 3
EC - Ecuador 3
LK - Sri Lanka 3
NG - Nigeria 3
PT - Portogallo 3
SA - Arabia Saudita 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
CR - Costa Rica 2
LU - Lussemburgo 2
NO - Norvegia 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
TN - Tunisia 2
TW - Taiwan 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
VE - Venezuela 1
Totale 9.205
Salva come PNG Salva come JPEG
Città #
Chandler 640
Warsaw 459
Singapore 331
Ashburn 270
Fairfield 191
Ann Arbor 165
Dublin 163
Dearborn 150
Rome 129
New York 126
Wilmington 126
Woodbridge 120
Jakarta 108
Seattle 107
Jacksonville 101
Nanjing 100
San Mateo 94
Milan 84
Cattolica 78
Houston 78
The Dalles 66
Beijing 65
Cambridge 62
Boston 59
Bremen 51
Princeton 51
Helsinki 49
Chicago 47
Munich 44
Hefei 43
Marseille 43
Brussels 42
Moscow 36
Los Angeles 34
Nürnberg 32
Frankfurt am Main 31
Lawrence 31
Redwood City 30
Izmir 29
North Bergen 28
Hong Kong 27
Seoul 27
Pune 26
Abidjan 24
Norwalk 23
Boardman 22
Kraków 22
London 22
Redmond 21
Kunming 20
Nanchang 20
Lancaster 19
Nuremberg 18
São Paulo 17
Hebei 16
Hangzhou 15
Mountain View 15
Leawood 14
Shenyang 14
Tianjin 14
Toronto 14
Busto Arsizio 13
Portsmouth 13
Santa Maria 13
Falls Church 12
Jiaxing 12
Phoenix 12
Tokyo 12
Düsseldorf 11
Turku 11
Amsterdam 10
Andover 10
Augusta 10
Brno 10
Falkenstein 10
Guangzhou 10
Vienna 10
Brasília 9
Changsha 9
Jinan 9
San Francisco 9
Dong Ket 8
Fremont 8
Lauterbourg 8
Ningbo 8
San Diego 8
Simi Valley 8
University Park 8
Zhengzhou 8
Zurich 8
Charlotte 7
Detroit 7
Fuzhou 7
Paris 7
Parma 7
Rio de Janeiro 7
Roubaix 7
Shanghai 7
Washington 7
Belo Horizonte 6
Totale 5.259
Salva come PNG Salva come JPEG
Nome #
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue 398
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 305
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 288
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 279
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 251
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 214
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 204
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 182
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 157
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 154
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue. 149
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 147
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 144
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 134
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 133
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor. 129
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 128
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 124
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 122
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 122
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 119
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 116
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 108
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 108
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 106
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 105
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 104
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 102
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 102
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 96
Sarilumab use in severe SARS-CoV-2 pneumonia 96
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 94
Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis 92
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 91
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 90
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 89
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 89
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 86
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 86
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 81
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 80
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 80
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 79
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 78
Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus 76
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 76
Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients 75
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study. 75
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 72
Effects of l-Arginine Plus Vitamin C Supplementation on l-Arginine Metabolism in Adults with Long COVID: Secondary Analysis of a Randomized Clinical Trial 71
Malnutrition in COVID-19 survivors: prevalence and risk factors 70
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 70
Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve 70
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 70
Is it necessary to be citrullinated to have restricted clonotypes reacting with Collagen type II? Comment to article "A novel HLA-DRB1*10:01 restricted T cell epitope from citrullinated type II collagen relevant for Rheumatoid Arthritis" 69
Correction to: Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: influence of the disease severity and therapy on the ovarian reserve (Endocrine, (2019), 63, 2, (369-375), 10.1007/s12020-018-1783-1) 69
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 68
Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES 67
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 67
Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: MicroRNA signature, histological, and ultrasound features 67
Weight Loss, The Obesity Paradox in Rheumatoid Arthritis: Is It a Paradox? Comment on the Article by Baker et al 67
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis 66
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 66
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 66
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 65
COVID-19 atypical Parsonage-Turner syndrome: a case report 63
The B side of rheumatoid arthritis pathogenesis 60
Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: A case report 60
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 59
Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases 59
Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study. 58
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 58
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 58
Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study 57
Depression and Endothelial Dysfunction in Psoriatic Arthritis: Is There Any Possible Relationship? 57
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 56
Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial 55
Basophil activation and serum IL-5 levels as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti-IL-5 drugs 54
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 50
Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”? 50
Psoriatic arthritis and depressive symptoms: does systemic inflammation play a role? 50
Intensive training programme for ultrasound-guided minimally invasive synovial tissue biopsy on knees and wrists in different phases of inflammation 49
JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy 49
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 49
Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity 47
Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig 47
Loss of α2-6 sialylation promotes the transformation of synovial fibroblasts into a pro-inflammatory phenotype in arthritis 46
Pro Nerve Growth Factor and Its Receptor p75NTR Activate Inflammatory Responses in Synovial Fibroblasts: A Novel Targetable Mechanism in Arthritis 46
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 44
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 38
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 37
The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis 36
Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons 33
Effects of house dust mite subcutaneous immunotherapy in real-life. Immunological and clinical biomarkers and economic impact analysis 32
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 32
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 32
Mitochondria-Derived Vesicles and Inflammatory Profiles of Adults with Long COVID Supplemented with Red Beetroot Juice: Secondary Analysis of a Randomized Controlled Trial 31
Synovial B cells of rheumatoid arthritis express ZAP-70 which increases the survival and correlates with the inflammatory and autoimmune phenotype 29
Could we use a lower dose of rituximab to treat rheumatoid arthritis in clinical practice: Pros and cons? 28
Beetroot juice intake positively influenced gut microbiota and inflammation but failed to improve functional outcomes in adults with long COVID: A pilot randomized controlled trial 26
Totale 9.138
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.863
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.863
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202050 0 0 0 0 0 0 0 0 0 0 0 50
2020/2021732 68 60 47 50 89 37 78 12 92 70 100 29
2021/2022915 119 62 38 61 65 29 28 103 41 67 133 169
2022/20231.893 220 239 150 300 117 224 92 140 235 62 63 51
2023/20241.112 42 253 46 64 45 189 81 52 14 78 160 88
2024/20251.999 48 47 176 94 200 91 101 98 357 263 476 48
Totale 9.384